Results 11 to 20 of about 831,586 (304)

Mechanism and transfusion strategy of immunogenic platelet transfusion refractoriness

Zhongguo shuxue zazhi, 2022
Platelet transfusion is an irreplaceable method to treat patients with platelet reduction in Hematology Department and Oncology Department. However, immunogenic platelet transfusion refractoriness is a huge challenge to patients who require repeatedly ...
Juan SAI, Li TIAN
doaj   +1 more source

Transfusion effect of 0.5-dose of apheresis platelet in pediatric patients

Zhongguo shuxue zazhi, 2023
Objective To investigate the transfusion effect of 0.5-dose of apheresis platelet in pediatric patients. Methods A total of 195 children who underwent 0.5-dose platelet transfusion from August 2021 to June 2022 were enrolled, and the platelet count ...
Lijuan QIU, Zida ZHEN, Xiaoyan FU, Shuxuan MA   +3 more
doaj   +1 more source

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.

New England Journal of Medicine, 2023
BACKGROUND Transfusion guidelines regarding platelet-count thresholds before the placement of a central venous catheter (CVC) offer conflicting recommendations because of a lack of good-quality evidence.
Floor L F van Baarle, E. K. van de Weerdt, W. J. van der Velden, R. A. Ruiterkamp, P. Tuinman, P. Ypma, Walter M van den Bergh, A. Demandt, Emile D. Kerver, A. Jansen, Peter E. Westerweel, S. Arbous, R. Determann, W. V. van Mook, M. Koeman, Anja B. U. Mäkelburg, K. V. van Lienden, J. Binnekade, B. Biemond, A. Vlaar   +19 more
semanticscholar   +1 more source

Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness

Asian Journal of Transfusion Science, 2021
Conventional platelet transfusion may not be adequate to deal with platelet transfusion refractoriness (PTR), and therefore human leukocyte antigen (HLA) or human platelet antigen (HPA) matched and platelet crossmatch compatible units are recommended ...
Gayathiri K Chellaiya, Chandran K Nair, Vineetha Raghavan, R Jesu Pandian, Roshan Vinod, Mohandoss Murugesan   +5 more
doaj   +1 more source

Two-year outcomes following a randomised platelet transfusion trial in preterm infants

Archives of Disease in Childhood, 2023
Objective Assess mortality and neurodevelopmental outcomes at 2 years of corrected age in children who participated in the PlaNeT-2/MATISSE (Platelets for Neonatal Transfusion - 2/Management of Thrombocytopenia in Special Subgroup) study, which reported ...
C. Moore, A. D’Amore, S. Fustolo-Gunnink, C. Hudson, Alice Newton, B. Santamaria, A. Deary, R. Hodge, V. Hopkins, A. Mora, C. Llewelyn, V. Venkatesh, R. Khan, K. Willoughby, W. Onland, Karin Fijnvandraat, H. New, P. Clarke, E. Lopriore, T. Watts, S. Stanworth, A. Curley   +21 more
semanticscholar   +1 more source

Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative – Control/Avoidance of Bleeding (TAXI-CAB)

Pediatric Critical Care Medicine, 2022
Supplemental Digital Content is available in the text. OBJECTIVES: Critically ill children frequently receive plasma and platelet transfusions. We sought to determine evidence-based recommendations, and when evidence was insufficient, we developed expert-
Marianne E. Nellis, O. Karam, Stacey L. Valentine, Scot T. Bateman, Kenneth E. Remy, J. Lacroix, J. Cholette, M. Bembea, R. Russell, M. Steiner, S. Goobie, M. Tucci, P. Stricker, S. Stanworth, M. Delaney, L. Lieberman, J. Muszynski, D. Bauer, Katherine M. Steffen, D. Nishijima, J. Ibla, S. Emani, A. Vogel, T. Haas, R. Goel, G. Crighton, Diana Delgado, Michelle Demetres, R. Parker   +28 more
semanticscholar   +1 more source

Platelet transfusions [PDF]

The Lancet, 2007
Ever since platelet transfusions were shown to reduce mortality from haemorrhage in patients with acute leukaemia in the 1950s, the use of this therapy has steadily grown to become an essential part of the treatment of cancer, haematological malignancies, marrow failure, and haematopoietic stem cell transplantation.
Stroncek, David F., Rebulla, Paolo
openaire   +3 more sources

Impact of platelet transfusion on outcomes in trauma patients

Critical Care, 2022
Background Trauma-induced coagulopathy includes thrombocytopenia and platelet dysfunction that impact patient outcome. Nevertheless, the role of platelet transfusion remains poorly defined.
S. Hamada, D. Garrigue, H. Nougué, A. Meyer, M. Boutonnet, E. Meaudre, A. Culver, E. Gaertner, G. Audibert, B. Vigué, J. Duranteau, A. Godier, Paer-Selim Gérard Tobias Thomas Anatole Olivier Marc Julien L Abback Audibert Gauss Geeraerts Harrois Langeron L, P. Abback, G. Audibert, T. Gauss, T. Geeraerts, A. Harrois, O. Langeron, M. Leone, J. Pottecher, L. Stecken, J. Hanouz   +22 more
semanticscholar   +1 more source

Platelet transfusion in adults: an update.

Transfusion Clinique et Biologique, 2022
Many patients worldwide receive platelet components (PCs) through the transfusion of diverse types of blood components. PC transfusions are essential for the treatment of central thrombocytopenia of diverse causes, and such treatment is beneficial in ...
O. Garraud, H. Hamzeh-Cognasse, E. Chalayer, A. Duchez, B. Tardy, P. Oriol, A. Haddad, D. Guyotat, F. Cognasse   +8 more
semanticscholar   +1 more source

Evaluation and management of platelet transfusion refractoriness

Blood Research, 2022
Platelet transfusion refractoriness (PTR), in which platelet counts do not increase after transfusion, occurs in many patients receiving platelet transfusions. PTR is a clinical condition that can harm patients.
Hee-Jeong Youk, Sang-Hyun Hwang, Heung-Bum Oh, D. Ko   +3 more
semanticscholar   +1 more source